Literature DB >> 15663908

Statins and the prevention of stroke in diabetes.

Mary Ann Banerji1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15663908     DOI： 10.1007/s11892-005-0058-4

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  21 in total

1.  Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atherosclerosis Study).

Authors:  S M Haffner; R D Agostino; M F Saad; D H O'Leary; P J Savage; M Rewers; J Selby; R N Bergman; L Mykkänen
Journal:  Am J Cardiol       Date:  2000-06-15       Impact factor: 2.778

Review 2.  Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis.

Authors:  Pierre Amarenco; Julien Labreuche; Philippa Lavallée; Pierre-Jean Touboul
Journal:  Stroke       Date:  2004-10-28       Impact factor: 7.914

3.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Authors:  Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew W Neil; Shona J Livingstone; Margaret J Thomason; Michael I Mackness; Valentine Charlton-Menys; John H Fuller
Journal:  Lancet       Date:  2004 Aug 21-27       Impact factor: 79.321

4.  Is diabetes mellitus a cardiovascular disease risk equivalent for fatal stroke in women? Data from the Women's Pooling Project.

Authors:  Jennifer E Ho; Furcy Paultre; Lori Mosca
Journal:  Stroke       Date:  2003-12-01       Impact factor: 7.914

5.  UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.

Authors:  Viti Kothari; Richard J Stevens; Amanda I Adler; Irene M Stratton; Susan E Manley; H Andrew Neil; Rudy R Holman
Journal:  Stroke       Date:  2002-07       Impact factor: 7.914

Review 6.  Treatment of insulin resistance in diabetes mellitus.

Authors:  Harold E Lebovitz; Mary Ann Banerji
Journal:  Eur J Pharmacol       Date:  2004-04-19       Impact factor: 4.432

7.  Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

Authors:  Steven E Nissen; E Murat Tuzcu; Paul Schoenhagen; B Greg Brown; Peter Ganz; Robert A Vogel; Tim Crowe; Gail Howard; Christopher J Cooper; Bruce Brodie; Cindy L Grines; Anthony N DeMaria
Journal:  JAMA       Date:  2004-03-03       Impact factor: 56.272

8.  Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration.

Authors: 
Journal:  Lancet       Date:  1995 Dec 23-30       Impact factor: 79.321

9.  Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.

Authors:  Rory Collins; Jane Armitage; Sarah Parish; Peter Sleight; Richard Peto
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

10.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245
View more
  1 in total

1.  Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS).

Authors:  M Raikou; A McGuire; H M Colhoun; D J Betteridge; P N Durrington; G A Hitman; H A W Neil; S J Livingstone; V Charlton-Menys; J H Fuller
Journal:  Diabetologia       Date:  2007-01-31       Impact factor: 10.122
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.